BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Madhukar S. Patel, Jahan Mohebali, Jigesh A. Shah, James F. Markmann, Parsia A. Vagefi. Readmission following liver transplantation: an unwanted occurrence but an opportunity to actHPB 2016; 18(11): 936 doi: 10.1016/j.hpb.2016.08.003
2
Maria Stepanova, Trevor Locklear, Nila Rafiq, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi. Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryClinical Transplantation 2016; 30(12): 1570 doi: 10.1111/ctr.12859
3
Lucia Golfieri, Stefano Gitto, Maria Cristina Morelli, Antonio Daniele Pinna, Silvana Grandi, Pietro Andreone. Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of viewExpert Review of Anti-infective Therapy 2017; 15(8): 759 doi: 10.1080/14787210.2017.1362334
4
Kristopher P. Croome, Amit K. Mathur, Surakit Pungpapong, David D. Lee, Adyr A. Moss, Charles B. Rosen, Julie K. Heimbach, C. Burcin Taner. Equivalent Outcomes With Retransplantation and Primary Liver Transplantation in the Direct-acting Antiviral EraTransplantation 2019; 103(6): 1168 doi: 10.1097/TP.0000000000002460
5
S. Trapani, L. Rizzato, L. Masiero, A. Ricci, V. Morabito, D. Peritore, P. Fiaschetti, E. Del Sordo, A.R. Cacciotti, A. Montemurro, A. Nanni Costa. Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting AntiviralsTransplantation Proceedings 2017; 49(4): 658 doi: 10.1016/j.transproceed.2017.02.039
6
Silvia Martini, Maria Francesca Donato, Chiara Mazzarelli, Maria Rendina, Ubaldo Visco-Comandini, Daniela Filì, Alice Gianstefani, Stefano Fagiuoli, Mario Melazzini, Simona Montilla, Luca Pani, Sandra Petraglia, Pierluigi Russo, Maria Paola Trotta, Paola Carrai, Paolo Caraceni. The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experienceLiver International 2018; 38(4): 733 doi: 10.1111/liv.13588
7
Tete Ukpong, Parvez Mantry. PRO: Patients With Decompensated Cirrhosis Listed for Liver Transplantation Should Be Treated PretransplantClinical Liver Disease 2019; 14(1): 16 doi: 10.1002/cld.808
8
Aijaz Ahmed, Stevan A. Gonzalez, George Cholankeril, Ryan B. Perumpail, Justin McGinnis, Sammy Saab, Rachel Beckerman, Zobair M. Younossi. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United StatesHepatology 2017; 66(1): 46 doi: 10.1002/hep.29137
9
Seyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, Heidar Sharafi, Nasser Ebrahimi Daryani, Shahin Merat, Minoo Mohraz, Masoud Mardani, Mohamad Reza Fattahi, Hossein Poustchi, Mehri Nikbin, Mahmood Nabavi, Peyman Adibi, Masood Ziaee, Bita Behnava, Mohammad Saeid Rezaee-Zavareh, Massimo Colombo, Hatef Massoumi, Abdul Rahman Bizri, Bijan Eghtesad, Majid Amiri, Ali Namvar, Khashayar Hesamizadeh, Reza Malekzadeh. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineHepatitis Monthly 2016; 16(8) doi: 10.5812/hepatmon.guideline
10
Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis CWorld Journal of Hepatology 2017; 9(7): 352-367 doi: 10.4254/wjh.v9.i7.352